The BET Family of Proteins Targets Moloney Murine Leukemia Virus Integration near Transcription Start Sites
Authors:
- Jonas DemeulemeesterJDJonas Demeulemeester
- Frederic D. BushmanFBFrederic D. Bushman
- Katrien BusschotsKBKatrien Busschots
- Zeger DebyserZDZeger Debyser
Open Access
- 1 November 2013
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 5 (4) , 886-894
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteinsGenome Biology, 2012
- An Essential Role for LEDGF/p75 in HIV IntegrationScience, 2006
- Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site SelectionPLOS Pathogens, 2006
- A role for LEDGF/p75 in targeting HIV DNA integrationNature Medicine, 2005
- Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vectorThe Lancet, 2004
- Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site PreferencesPLOS Biology, 2004
- Transcription Start Regions in the Human Genome Are Favored Targets for MLV IntegrationScience, 2003
- HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human CellsJournal of Biological Chemistry, 2003
- Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene TherapyNew England Journal of Medicine, 2002
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000